α-Methyl-Tryptophan Inhibits SLC6A14 Expression and Exhibits Immunomodulatory Effects in Crohn’s Disease
YongCheng Su,1,* Jiangquan Li,1,* Yijia Chen,2,* Jiachen Bao,2 Ziyu Lei,1 Miaomiao Ma,1 Wenqing Zhang,1 Qian Liu,3 Beibei Xu,4 Tianhui Hu,1,3 Yiqun Hu2 1Xiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian,...
Saved in:
Main Authors: | Su Y, Li J, Chen Y, Bao J, Lei Z, Ma M, Zhang W, Liu Q, Xu B, Hu T, Hu Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/-methyl-tryptophan-inhibits-slc6a14-expression-and-exhibits-immunomodu-peer-reviewed-fulltext-article-JIR |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prominence of Microbiota to Predict Fibrous Stenosis in Crohn’s Disease
by: Yang X, et al.
Published: (2025-02-01) -
Systemic Immune-Inflammation Index: A Promising, Non-Invasive Biomarker for Crohn’s Disease Activity and Severity Assessment
by: Deng Y, et al.
Published: (2025-01-01) -
Innovative Assessment of Crohn’s Disease: An Activity Prediction Tool Combining Laboratory Data and Imaging [Letter]
by: Wang F, et al.
Published: (2025-02-01) -
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01) -
New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01)